SMS Oncology publicerar idag om samarbetet för genomförandet av fas 2-studien med Foxy-5, vilket WntResearch tidigare meddelat 12 juli
WntResearch and SMS-oncology signed an agreement for the implementation of the phase II study with Foxy-5Malmö, Sweden and Schiphol, the Netherlands (15 August 2018) – WntResearch AB (“WntResearch”) and Specialized Medical Services-oncology BV (“SMS-oncology”) announce that SMS-oncology has been selected as the contract research organization (CRO) to conduct the phase II study with Foxy-5 in patients with colon cancer. WntResearch designed a clinical phase II trial with Foxy-5 as neoadjuvant therapy in colon cancer patients without evidence of metastases present. Their lead program Foxy-